Paget's disease of bone represents the most flagrant example of disordered bone remodeling in which abnormal osteoclasts demonstrate increased levels of bone resorption followed by an abundance of new bone formation. The primary cellular abnormality occurs in the osteoclasts. A possible viral etiology has been suggested for Paget's disease, because the osteoclasts express paromyxovirus nucleocapsid antigens, contain viral and cytoplasmic nuclear inclusions, and have been shown to express viral messenger RNAs by in situ hybridization studies. However, the mechanism responsible for the abnormal bone remodeling in Paget's disease have not been clearly defined. In this proposal we will use our recently described model for pagetic osteoclast formation to further characterize the mechanisms responsible for the abnormal osteoclast formation in Paget's disease. We have recently reported that multinucleated cells that have the characteristics of pagetic osteoclasts are formed in long term marrow cultures of marrow mononuclear cells from patients with Paget's disease. These characteristics include increased cell number and cell size, increased tartrate resistant acid phosphatase activity, increased sensitivity to 1,25 dihydroxyvitamin D3, increased rates of formation and ultrastructural features that are characteristic of pagetic osteoclasts. These multinucleated cells express measles and RSV nucleocapsid antigens similar to pagetic osteoclasts, and conditioned media produced by these cells contains factors that stimulate osteoclast-like cell formation in normal marrow cultures. In addition, we have found that immature cells in the osteoclast lineage are increased in patients with Paget's disease and have begun a preliminary characterization of these precursor cells. Thus, this model system should allow us the unique opportunity to examine in detail the pathophysiology of Paget's disease. In this proposal we plan to: 1) prepare a cDNA library from pagetic MNC in order to identify, sequence and clone viral cDNA's expressed by these cells and to characterize factors produced by pagetic MNC that enhance osteoclast formation; 2) determine the role of the marrow microenvironment in the increase of early osteoclast precursors, and the effects of the microenvironment on MNC formation; 3) identify and extensively characterize the precursor for the MNC in pagetic marrow and 4) establish an animal model of Paget's disease.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Xu, S C; Harris, M A; Rubenstein, J L et al. (2001) Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. DNA Cell Biol 20:359-65
Ji, X; Chen, D; Xu, C et al. (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab 18:132-9
Yoneda, T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-5
Nishimura, R; Moriyama, K; Yasukawa, K et al. (1998) Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 13:777-85
Xu, C; Ji, X; Harris, M A et al. (1998) A clonal chondrocytic cell line derived from BMP-2/T antigen-expressing transgenic mouse. In Vitro Cell Dev Biol Anim 34:359-63
Reddy, S V; Roodman, G D (1998) Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:1-17
Chen, D; Ji, X; Harris, M A et al. (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305
Roodman, G D (1998) Osteoclast differentiation and activity. Biochem Soc Trans 26:7-13
Hughes, D E; Boyce, B F (1997) Apoptosis in bone physiology and disease. Mol Pathol 50:132-7
Mundy, G R (1997) Growth factors as potential therapeutic agents in osteoporosis. Instr Course Lect 46:495-8

Showing the most recent 10 out of 49 publications